نتائج البحث - "Okpara, Chinyere"

1

دورية أكاديمية

Lenvatinib plus pembrolizumab versus sunitinib in first-line treatment of advanced renal cell carcinoma:final prespecified overall survival analysis of CLEAR, a phase III study

المصدر: Motzer , R J , Porta , C , Eto , M , Powles , T , Grünwald , V , Hutson , T E , Alekseev , B , Rha , S Y , Merchan , J , Goh , J C , Lalani , A K A , De Giorgi , U , Melichar , B , Hong , S H , Gurney , H , Mendez Vidal , M J , Kopyltsov , E , Tjulandin , S , Gordoa , T A , Kozlov , V , Alyasova , A , Winquist , E , ....

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1200/JCO.23.01569Test
https://researchers.mq.edu.au/en/publications/fa0904f7-1e52-4edd-abcc-7067409e1516Test
https://research-management.mq.edu.au/ws/files/340649651/Publisher_version_open_access_.pdfTest
http://www.scopus.com/inward/record.url?scp=85189700658&partnerID=8YFLogxKTest

View record in BASE

2

دورية أكاديمية

Using electronic health records to enhance surveillance of diabetes in children, adolescents and young adults: a study protocol for the DiCAYA Network

المؤلفون: Hirsch, Annemarie G, Conderino, Sarah, Crume, Tessa L, Liese, Angela D, Bellatorre, Anna, Bendik, Stefanie, Divers, Jasmin, Anthopolos, Rebecca, Dixon, Brian E, Guo, Yi, Imperatore, Giuseppina, Lee, David C, Reynolds, Kristi, Rosenman, Marc, Shao, Hui, Utidjian, Levon, Thorpe, Lorna E, The DiCAYA Study Group, Bailey, Charles, Forrest, Christopher, Maltenfort, Mitch, Shah, Amy, Mendonca, Eneida A, Todd Alonso, G, Deakyne-Davies, Sara, Bunnell, Tim, Kazak, Anne, Kitzmiller, Melody, Kamboj, Manmohan, Christakis, Dimitri, Ranade, Daksha, DeWalle, Joseph J, Lester Kirchner, H, Lewis, Meredith, Mercer, Dione G, Nordberg, Cara M, Poissant, Amy, Schwartz, Brian S, Grannis, Shaun, Park, Seho, Allen, Katie, Roberts, Anna, Valvi, Nimish, Warvel, Jeff, Wiensch, Ashley, Hannon, Tamara, Chang, John, Lustigova, Eva, McCarthy, Don, Mefford, Matthew T, Wei, Rong, Zhou, Hui, Zhang, Lu, Lales, George, Wong, Anthony, Zelinski, Allison, Luo, Yuan, Weiner, Mark, Rivera, Pedro, Carton, Thomas, Nauman, Elizabeth, Lehmann, Harold P, Zhong, Victor W, Akerman, Meredith, Fair, Andrew, Guillaume, Jessica, Islam, Shahidul, Jacobson, Alan, Okpara, Chinyere, Rajan, Anand, Titus, Andrea, Crume, Tessa, Dabelea, Dana, Anderson, Theresa, Conway, Rebecca, Ong, Toan, Pattee, Jack, Burgett, Shawna, Shiferaw, Bethlehem, Shenkman, Elizabeth A, Bost, Sarah J, Donahoo, William T, Hogan, William R, Li, Piaopiao, Lyu, Tianchen, Prosperi, Mattia, Wu, Yonghui, Cai, Bo, Knight, Lisa, Rudisill, Caroline, Stucker, Jessica, Bowlby, Deborah, Obeid, Jihad S, Apperson, Elaine, Ewing, Alex, Pavkov, Meda, Rolka, Deborah B, Bian, Jiang

مصطلحات موضوعية: Diabetes and endocrinology

وصف الملف: text/html

العلاقة: http://bmjopen.bmj.com/cgi/content/short/14/1/e073791Test; http://dx.doi.org/10.1136/bmjopen-2023-073791Test

الإتاحة: https://doi.org/10.1136/bmjopen-2023-073791Test
http://bmjopen.bmj.com/cgi/content/short/14/1/e073791Test

View record in BASE

3

دورية أكاديمية

Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

المصدر: Frontiers in Oncology ; volume 13 ; ISSN 2234-943X

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.3389/fonc.2023.1343027Test

View record in BASE

4

دورية أكاديمية

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

المساهمون: Gennigens, Christine

المصدر: Journal of Clinical Oncology, JCO2301569 (2024-01-16)

مصطلحات موضوعية: Cancer Research, Oncology, Human health sciences, Sciences de la santé humaine, Oncologie

العلاقة: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.01569Test; urn:issn:0732-183X; urn:issn:1527-7755

الوصول الحر: https://orbi.uliege.be/handle/2268/315809Test

View record in ORBi

5

دورية أكاديمية

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab

المؤلفون: Colombo, Nicoletta, Lorusso, Domenica, Monk, Bradley J, Slomovitz, Brian, Hasegawa, Kosei, Nogueira-Rodrigues, Angélica, Zale, Melissa, Okpara, Chinyere E, Barresi, Gianmaria, McKenzie, Jodi, Makker, Vicky

المصدر: The Oncologist ; volume 29, issue 1, page 25-35 ; ISSN 1083-7159 1549-490X

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1093/oncolo/oyad201Test
https://academic.oup.com/oncolo/article-pdf/29/1/25/55119364/oyad201.pdfTest

View record in BASE

6

دورية أكاديمية

Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

المصدر: Frontiers in Oncology ; volume 13 ; ISSN 2234-943X

الإتاحة: https://doi.org/10.3389/fonc.2023.1223282Test

View record in BASE

7

دورية أكاديمية

Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial

المؤلفون: Yang, James Chih-Hsin, Han, Baohui, De La Mora Jiménez, Emmanuel, Lee, Jong-Seok, Koralewski, Piotr, Karadurmus, Nuri, Sugawara, Shunichi, Livi, Lorenzo, Basappa, Naveen S., Quantin, Xavier, Dudnik, Julia, Ortiz, Diego Moran, Mekhail, Tarek, Okpara, Chinyere E., Dutcus, Corina, Zimmer, Zachary, Samkari, Ayman, Bhagwati, Niyati, Csőszi, Tibor

المصدر: Journal of Thoracic Oncology ; ISSN 1556-0864

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

الإتاحة: https://doi.org/10.1016/j.jtho.2023.12.023Test
https://api.elsevier.com/content/article/PII:S1556086423024322?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1556086423024322?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011):A Phase 3, Randomized, Double-Blind Trial

المصدر: Matsubara , N , de Wit , R , Balar , A V , Siefker-Radtke , A O , Zolnierek , J , Csoszi , T , Shin , S J , Park , S H , Atduev , V , Gumus , M , Su , Y L , Karaca , S B , Cutuli , H J , Sendur , M A N , Shen , L , O'Hara , K , Okpara , C E , Franco , S , Moreno , B H , Grivas , P & Loriot , Y 2024 , ' Pembrolizumab ....

العلاقة: https://pure.eur.nl/en/publications/774348f5-8f99-4404-8e6b-9a0201f6dd8aTest

الإتاحة: https://doi.org/10.1016/j.eururo.2023.08.012Test
https://pure.eur.nl/en/publications/774348f5-8f99-4404-8e6b-9a0201f6dd8aTest
http://www.scopus.com/inward/record.url?scp=85172986667&partnerID=8YFLogxKTest

View record in BASE

9

دورية أكاديمية

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab

المؤلفون: Colombo, Nicoletta, Lorusso, Domenica, Monk, Bradley J, Slomovitz, Brian, Hasegawa, Kosei, Nogueira-Rodrigues, Angélica, Zale, Melissa, Okpara, Chinyere E, Barresi, Gianmaria, McKenzie, Jodi, Makker, Vicky

المساهمون: Colombo, N, Lorusso, D, Monk, B, Slomovitz, B, Hasegawa, K, Nogueira-Rodrigues, A, Zale, M, Okpara, C, Barresi, G, Mckenzie, J, Makker, V

مصطلحات موضوعية: adverse reaction, endometrial cancer, lenvatinib, pembrolizumab

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37523661; info:eu-repo/semantics/altIdentifier/wos/WOS:001039945300001; volume:29; issue:1; firstpage:25; lastpage:35; numberofpages:11; journal:THE ONCOLOGIST; https://hdl.handle.net/10281/434280Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85181761032

الإتاحة: https://doi.org/10.1093/oncolo/oyad201Test
https://hdl.handle.net/10281/434280Test

View record in BASE

10

دورية أكاديمية

Avoidance of Care: How Healthcare Affordability Influenced COVID-19 Disease Severity and Outcomes

المؤلفون: Okpara, Chinyere J, Divers, Jasmin, Winner, Megan

المصدر: American Journal of Epidemiology ; ISSN 0002-9262 1476-6256

مصطلحات موضوعية: General Medicine

الإتاحة: https://doi.org/10.1093/aje/kwae022Test

View record in BASE

تنقيح النتائج